| Code | 52468 | ||||||||||
| MA number | 44/0418/08-S | ||||||||||
| Product Form: | con ijf 10x2 ml/50 mg (liek.inj.skl.) | ||||||||||
| MA Status: | D - Marketing Authorisation valid for an unlimited period | ||||||||||
| Type of procedure: | Decentralised | ||||||||||
| MAH, country: | Sandoz Pharmaceuticals d.d., Slovenia | ||||||||||
| Therapeutic Class: | 44 - CYTOSTATICA | ||||||||||
| ATC: |
|
||||||||||
| Shelf life: | 36 | ||||||||||
| Container: | glass vial | ||||||||||
| Route of admin.: | Intravenous use |
| Prescription Status: | Medicinal product subject to medical prescription. |
| Legal basis: | Article 10(1) generic application |
| MA issued: | 04.09.2008 |
| SPC: |
SPC_Fludarabin Sandoz 25 mg_ml injekčný alebo infúzny koncentrát_02.2022.pdf
|
| PIL: |
PIL_Fludarabin Sandoz 25 mg_ml injekčný alebo infúzny koncentrát_02.2022.pdf
|
| Safety feature | Yes |
| Data update: | 23.03.2021 |
